Synthesis of Substances for Pharmacological Testing
Closed Solicitation Posted
- Solicitation number
- D-26-DO-0018
- Agency
-
Drug Enforcement Administration
Department of Justice
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- 6810 Chemicals
- Place of performance
- Dulles, Virginia 20166, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Drug Enforcement Administration seeks pricing for synthesis of 15 line items of specialized pharmaceutical substances for pharmacological testing, with quotations due September 25, 2026 at 5:00 PM EST and questions due September 23, 2026 at 2:00 PM EST.
Place of performance is Dulles, VA 20166. The line items include N-sec-butyl Butylone (1g), Methiodone (200mg), Spirofluorphine (1g), Methylorphine (1g), Mexazolam (500mg), Cyclopropylflualprazolam (1g), and nine additional related compounds. Delivery is required January 31, 2027. The procurement is unrestricted and prepared under FAR Part 12 as a commercial items purchase. The NAICS code is 325199, All Other Basic Organic Chemical Manufacturing, with a business size standard of 1,250 employees. The PSC is 6810, Chemicals.
Award will be made on an all-or-none basis to a single responsible offeror using lowest-price technically-acceptable source selection. Quotations must be submitted by email to Ms. Angel Barkley at angel.d.barkley@dea.gov. Offerors must be registered in SAM prior to award and must complete FAR 52.212-3 representations and certifications. The solicitation incorporates FAR and Justice Acquisition Regulation clauses addressing commercial items procurement, personnel security, information security, privacy, whistleblower protections, and compliance obligations.
Notice text
Synthesis of Substances for Pharmacological Testing
Files
| File | Type | Posted |
|---|---|---|
| A28 - Combined Synopsis_Solicitation.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity